Contact
Please use this form to send email to PR contact of this press release:
FDA issues final decision to withdraw approval of Pepaxto (melphalan flufenamide)
TO:
Please use this form to send email to PR contact of this press release:
FDA issues final decision to withdraw approval of Pepaxto (melphalan flufenamide)
TO: